Donor immune cells take on autoimmune kidney disease in early trial
NCT ID NCT06557265
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests an experimental therapy called NKX019, which uses specially engineered immune cells from donors to target and calm overactive immune cells in people with lupus nephritis or primary membranous nephropathy. The trial involves 120 adults who have not responded to standard treatments. The main goals are to check safety and find the right dose, with early signs of kidney improvement also being tracked.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
NKX019 (a type of immune cell therapy called CAR NK cells, made from donor cells, targeting CD19)
What this could lead to
If successful, this could point toward a new treatment option for people with lupus nephritis or membranous nephropathy that doesn't respond to standard therapies.
What could go wrong
This is an early phase 1/2 trial with only 120 participants, so it's too soon to know if it works or is safe. There are risks from the chemotherapy used to prepare the body and from the cell therapy itself, including immune reactions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS NEPHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nkarta Investigational Site
RECRUITINGLittle Rock, Arkansas, 72201, United States
Contact
-
Nkarta Investigational Site
RECRUITINGTustin, California, 92780, United States
Contact
-
Nkarta Investigational Site
RECRUITINGGainesville, Florida, 32601, United States
Contact
-
Nkarta Investigational Site
WITHDRAWNMiami, Florida, 33133, United States
-
Nkarta Investigational Site
RECRUITINGPlantation, Florida, 33317, United States
Contact
-
Nkarta Investigational Site
RECRUITINGTampa, Florida, 33602, United States
Contact
-
Nkarta Investigational Site
RECRUITINGAtlanta, Georgia, 30303, United States
Contact
-
Nkarta Investigational Site
RECRUITINGChicago, Illinois, 60612, United States
Contact
-
Nkarta Investigational Site
RECRUITINGNew Orleans, Louisiana, 70112, United States
Contact
-
Nkarta Investigational Site
RECRUITINGWorcester, Massachusetts, 01608, United States
Contact
-
Nkarta Investigational Site
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact
-
Nkarta Investigational Site
RECRUITINGSummit, New Jersey, 07901, United States
Contact
-
Nkarta Investigational Site
RECRUITINGNew York, New York, 10007, United States
Contact
-
Nkarta Investigational Site
RECRUITINGStony Brook, New York, 11794, United States
Contact
-
Nkarta Investigational Site
RECRUITINGSyracuse, New York, 13202, United States
Contact
-
Nkarta Investigational Site
RECRUITINGDallas, Texas, 75201, United States
Contact
-
Nkarta Investigational Site
RECRUITINGHouston, Texas, 77002, United States
Contact
-
Nkarta Investigational Site
RECRUITINGParkville, Victoria, 3050, Australia
Contact
-
Nkarta Investigational Site
RECRUITINGManati, 00674, Puerto Rico
Contact